Huron Consulting Q4 Earnings Exceed Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy HURN?
Source: seekingalpha
- Strong Earnings Performance: Huron Consulting reported a Q4 non-GAAP EPS of $2.17, beating expectations by $0.22, which reflects the company's robust profitability and enhances investor confidence.
- Significant Revenue Growth: The company's Q4 revenue reached $441.96 million, marking a 10.7% year-over-year increase and exceeding expectations by $8.39 million, indicating sustained market demand that drives overall performance.
- Positive Future Outlook: Huron provided guidance for fiscal year 2026, projecting revenue between $1.78 billion and $1.86 billion, which demonstrates the company's confidence in future growth and offers clear expectations for investors.
- Favorable Market Reaction: The earnings beat is likely to enhance Huron's market valuation, attracting more investor interest and further solidifying its position in the consulting industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HURN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HURN
Wall Street analysts forecast HURN stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 144.450
Low
207.00
Averages
211.00
High
215.00
Current: 144.450
Low
207.00
Averages
211.00
High
215.00
About HURN
Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Huron Consulting Reports Mixed Q4 2025 Results, Shares Drop
- Revenue Growth Misses Expectations: Huron Consulting's Q4 revenue grew 10.7% year-over-year to $442 million, falling short of Wall Street expectations, which led to a 4.5% drop in stock price during morning trading, reflecting investor concerns over the revenue shortfall.
- Earnings Beat Analyst Estimates: Despite the revenue miss, adjusted earnings per share reached $2.17, surpassing analyst expectations and increasing from $1.90 in the same quarter last year, indicating an improvement in the company's profitability.
- Market Volatility Analysis: Huron's shares have experienced 12 moves greater than 5% over the past year, and today's price movement suggests that the market considers this news significant, though it does not fundamentally alter perceptions of the business.
- Year-to-Date Performance Review: Huron's stock has declined 28.7% since the beginning of the year, currently trading at $121.93 per share, which is 34.3% below its 52-week high of $185.58, indicating a cautious market outlook on its future growth.
See More
Huron Consulting Group Q4 2025 Earnings Call Insights
- Significant Revenue Growth: In Q4 2025, Huron Consulting Group reported revenues before reimbursable expenses (RBR) of $432.3 million, an 11.3% increase year-over-year, indicating strong performance in healthcare and commercial sectors, which has driven a fifth consecutive year of adjusted EBITDA margin expansion.
- Optimistic Future Outlook: Management projects 2026 RBR guidance between $1.78 billion and $1.86 billion, with adjusted EBITDA margins expected to range from 14.5% to 15%, reflecting confidence in future growth, particularly in healthcare and education sectors.
- AI and Automation Deployment: To date, the company has deployed over 100 AI and automation solutions aimed at helping health systems drive value, revenue growth, and cost savings, showcasing Huron's proactive approach in digital transformation.
- Shareholder Return Strategy: In 2025, Huron allocated $166 million for share repurchases and plans to invest an additional $70 million in Q1 2026, demonstrating a proactive stance on capital allocation aimed at enhancing shareholder value.
See More
Huron Consulting Q4 Earnings Exceed Expectations
- Strong Earnings Performance: Huron Consulting reported a Q4 non-GAAP EPS of $2.17, beating expectations by $0.22, which reflects the company's robust profitability and enhances investor confidence.
- Significant Revenue Growth: The company's Q4 revenue reached $441.96 million, marking a 10.7% year-over-year increase and exceeding expectations by $8.39 million, indicating sustained market demand that drives overall performance.
- Positive Future Outlook: Huron provided guidance for fiscal year 2026, projecting revenue between $1.78 billion and $1.86 billion, which demonstrates the company's confidence in future growth and offers clear expectations for investors.
- Favorable Market Reaction: The earnings beat is likely to enhance Huron's market valuation, attracting more investor interest and further solidifying its position in the consulting industry.
See More
Oversold Stocks in Industrials Sector Present Buying Opportunities
- Overview of Oversold Stocks: According to Benzinga Pro, several stocks in the industrials sector have relative strength indices (RSI) near or below 30, indicating they are undervalued and may present rebound opportunities.
- RSI Indicator Interpretation: The RSI is a momentum indicator that compares a stock's strength on up days to its strength on down days, helping traders better assess short-term stock performance and informing investment decisions.
- Key Oversold Companies: Avis Budget Group Inc (NASDAQ:CAR), Trueblue Inc (NYSE:TBI), and Huron Consulting Group Inc (NASDAQ:HURN) are notable companies in this sector with current RSIs below 30, suggesting potential investment value.
- Market Opportunity Analysis: As market attention on these oversold stocks increases, investors may seize this opportunity to buy at lower prices, potentially profiting from future market rebounds.
See More
Surge in Huron Consulting Options Trading Volume
- Surge in Options Volume: Huron Consulting Group Inc (HURN) has seen an options trading volume of 1,766 contracts today, equating to approximately 176,600 shares, which represents 79.3% of its average daily trading volume of 222,770 shares over the past month, indicating a significant increase in market interest.
- High Demand for Puts: Notably, the $145 strike put option has seen particularly high activity, with 1,500 contracts traded today, representing about 150,000 underlying shares of HURN, suggesting a growing bearish sentiment among investors regarding the stock's future price.
- Humana Options Activity: In parallel, Humana Inc (HUM) has recorded an options trading volume of 18,566 contracts today, representing approximately 1.9 million shares, or 74.6% of its average daily trading volume of 2.5 million shares over the past month, reflecting strong market engagement.
- Rising Call Demand: Specifically, the $200 strike call option has seen 1,607 contracts traded today, representing about 160,700 underlying shares of HUM, indicating a bullish outlook among investors for the stock's future performance.
See More
HURN Stock 52-Week High and Low Analysis
- Price Fluctuation Analysis: HURN's 52-week low is $120.2451 per share, while the high is $186.775, with the last trade at $152.21, indicating significant price volatility over the past year that could impact investor decisions and market sentiment.
- Technical Indicator Focus: The current stock price is below the 200-day moving average, suggesting potential short-term downside risk, prompting investors to closely monitor market trends to adjust strategies and mitigate potential losses.
- Market Sentiment Assessment: Despite the fluctuations in HURN's stock price over the past 52 weeks, the current price remains above the low point, indicating a degree of market confidence in the stock's fundamentals, which may attract long-term investors.
- Investor Strategy Adjustment: Investors should consider HURN's historical price volatility and current market conditions to formulate more effective investment strategies, especially as the stock approaches its low point, which may present rebound opportunities.
See More
Huron Consulting Reports Mixed Q4 2025 Results, Shares Drop
- Revenue Growth Misses Expectations: Huron Consulting's Q4 revenue grew 10.7% year-over-year to $442 million, falling short of Wall Street expectations, which led to a 4.5% drop in stock price during morning trading, reflecting investor concerns over the revenue shortfall.
- Earnings Beat Analyst Estimates: Despite the revenue miss, adjusted earnings per share reached $2.17, surpassing analyst expectations and increasing from $1.90 in the same quarter last year, indicating an improvement in the company's profitability.
- Market Volatility Analysis: Huron's shares have experienced 12 moves greater than 5% over the past year, and today's price movement suggests that the market considers this news significant, though it does not fundamentally alter perceptions of the business.
- Year-to-Date Performance Review: Huron's stock has declined 28.7% since the beginning of the year, currently trading at $121.93 per share, which is 34.3% below its 52-week high of $185.58, indicating a cautious market outlook on its future growth.
See More
Huron Consulting Group Q4 2025 Earnings Call Insights
- Significant Revenue Growth: In Q4 2025, Huron Consulting Group reported revenues before reimbursable expenses (RBR) of $432.3 million, an 11.3% increase year-over-year, indicating strong performance in healthcare and commercial sectors, which has driven a fifth consecutive year of adjusted EBITDA margin expansion.
- Optimistic Future Outlook: Management projects 2026 RBR guidance between $1.78 billion and $1.86 billion, with adjusted EBITDA margins expected to range from 14.5% to 15%, reflecting confidence in future growth, particularly in healthcare and education sectors.
- AI and Automation Deployment: To date, the company has deployed over 100 AI and automation solutions aimed at helping health systems drive value, revenue growth, and cost savings, showcasing Huron's proactive approach in digital transformation.
- Shareholder Return Strategy: In 2025, Huron allocated $166 million for share repurchases and plans to invest an additional $70 million in Q1 2026, demonstrating a proactive stance on capital allocation aimed at enhancing shareholder value.
See More
Huron Consulting Q4 Earnings Exceed Expectations
- Strong Earnings Performance: Huron Consulting reported a Q4 non-GAAP EPS of $2.17, beating expectations by $0.22, which reflects the company's robust profitability and enhances investor confidence.
- Significant Revenue Growth: The company's Q4 revenue reached $441.96 million, marking a 10.7% year-over-year increase and exceeding expectations by $8.39 million, indicating sustained market demand that drives overall performance.
- Positive Future Outlook: Huron provided guidance for fiscal year 2026, projecting revenue between $1.78 billion and $1.86 billion, which demonstrates the company's confidence in future growth and offers clear expectations for investors.
- Favorable Market Reaction: The earnings beat is likely to enhance Huron's market valuation, attracting more investor interest and further solidifying its position in the consulting industry.
See More
Oversold Stocks in Industrials Sector Present Buying Opportunities
- Overview of Oversold Stocks: According to Benzinga Pro, several stocks in the industrials sector have relative strength indices (RSI) near or below 30, indicating they are undervalued and may present rebound opportunities.
- RSI Indicator Interpretation: The RSI is a momentum indicator that compares a stock's strength on up days to its strength on down days, helping traders better assess short-term stock performance and informing investment decisions.
- Key Oversold Companies: Avis Budget Group Inc (NASDAQ:CAR), Trueblue Inc (NYSE:TBI), and Huron Consulting Group Inc (NASDAQ:HURN) are notable companies in this sector with current RSIs below 30, suggesting potential investment value.
- Market Opportunity Analysis: As market attention on these oversold stocks increases, investors may seize this opportunity to buy at lower prices, potentially profiting from future market rebounds.
See More
Surge in Huron Consulting Options Trading Volume
- Surge in Options Volume: Huron Consulting Group Inc (HURN) has seen an options trading volume of 1,766 contracts today, equating to approximately 176,600 shares, which represents 79.3% of its average daily trading volume of 222,770 shares over the past month, indicating a significant increase in market interest.
- High Demand for Puts: Notably, the $145 strike put option has seen particularly high activity, with 1,500 contracts traded today, representing about 150,000 underlying shares of HURN, suggesting a growing bearish sentiment among investors regarding the stock's future price.
- Humana Options Activity: In parallel, Humana Inc (HUM) has recorded an options trading volume of 18,566 contracts today, representing approximately 1.9 million shares, or 74.6% of its average daily trading volume of 2.5 million shares over the past month, reflecting strong market engagement.
- Rising Call Demand: Specifically, the $200 strike call option has seen 1,607 contracts traded today, representing about 160,700 underlying shares of HUM, indicating a bullish outlook among investors for the stock's future performance.
See More
HURN Stock 52-Week High and Low Analysis
- Price Fluctuation Analysis: HURN's 52-week low is $120.2451 per share, while the high is $186.775, with the last trade at $152.21, indicating significant price volatility over the past year that could impact investor decisions and market sentiment.
- Technical Indicator Focus: The current stock price is below the 200-day moving average, suggesting potential short-term downside risk, prompting investors to closely monitor market trends to adjust strategies and mitigate potential losses.
- Market Sentiment Assessment: Despite the fluctuations in HURN's stock price over the past 52 weeks, the current price remains above the low point, indicating a degree of market confidence in the stock's fundamentals, which may attract long-term investors.
- Investor Strategy Adjustment: Investors should consider HURN's historical price volatility and current market conditions to formulate more effective investment strategies, especially as the stock approaches its low point, which may present rebound opportunities.
See More
